Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H3I2NO3 |
| Molecular Weight | 390.9019 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(I)C=C(C=C1I)[N+]([O-])=O
InChI
InChIKey=UVGTXNPVQOQFQW-UHFFFAOYSA-N
InChI=1S/C6H3I2NO3/c7-4-1-3(9(11)12)2-5(8)6(4)10/h1-2,10H
| Molecular Formula | C6H3I2NO3 |
| Molecular Weight | 390.9019 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Ancylostoma caninum |
|||
Target ID: Uncinaria stenocephala |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | ANCYLOL Approved UseThe drug is used for the treatment of both dogs infested with hookworms (including Ancylostoma caninum, A. braziliense and
Uncinaria stenocephala) and cats infested with the hookworm A.
tubaeforme. Launch Date1964 |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 4.0 |
inconclusive [IC50 21.3174 uM] | |||
Page: 2.0 |
no [IC50 10.684 uM] | |||
Page: 36.0 |
no | |||
Page: 41.0 |
no | |||
Page: 39.0 |
no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 7 | 40 |
inconclusive |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 27.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| 2,6-Diiodo-4-nitrophenol, 2,6-diiodo-4-nitrophenyl acetate and 2,6-diiodo-4-nitroanisole: interplay of hydrogen bonds, iodo-nitro interactions and aromatic pi-pi-stacking interactions to give supramolecular structures in one, two and three dimensions. | 2002-08 |
Patents
Sample Use Guides
Dogs and cats: Disophenol is administered subcutaneously
at a dosage level equivalent to 4.5 milligrams
of disophenol per pound of
body weight. A second treatment may
be indicated 21 days after the initial
treatment.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/588311
Disophenol produced contracture of the rat cardiac muscle at concentrations of 100 and 1000 ng/ml and at the latter dose diastolic tension after 60 min perfusion was approximately 300 per cent of its initial value.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:33:32 GMT 2025
by
admin
on
Mon Mar 31 17:33:32 GMT 2025
|
| Record UNII |
39S5ZJ6SYN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
305-85-1
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
94733
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
m4671
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
206-170-4
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
9370
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
DTXSID4046573
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
C75215
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY | |||
|
39S5ZJ6SYN
Created by
admin on Mon Mar 31 17:33:32 GMT 2025 , Edited by admin on Mon Mar 31 17:33:32 GMT 2025
|
PRIMARY |